Clinical Trial Results: Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining skin transcriptional profiles in chronic plaque psoriasis patients treated with adalimumab biotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2026-06-24